PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma

被引：0
|
作者：
Carolina Noronha
Ana Sofia Ribeiro
Ricardo Taipa
Dina Leitão
Fernando Schmitt
Joaquim Reis
Cláudia Faria
Joana Paredes
机构：
[1] Centro Hospitalar Universitario do Porto,Neurosurgery Department, Hospital de Santo Antonio
[2] i3S- Institute for Investigation and Innovation in Health,Neuropathology Unit, Hospital de Santo Antonio
[3] Centro Hospitalar Universitario do Porto,Unit for Multidisciplinary Research in Biomedicine (UMIB), Institute of Biomedical Sciences Abel Salazar
[4] University of Porto,Faculty of Medicine
[5] University of Porto,Anatomy Department, Institute of Biomedical Sciences Abel Salazar
[6] University of Porto,Neurosurgery Department, Hospital de Santa Maria
[7] Centro Hospitalar Universitario Lisboa Norte,undefined
[8] IMM - Instituto de Medicina Molecular João Lobo Antunes,undefined
来源：
Journal of Neuro-Oncology | 2022年 / 156卷
关键词：
Glioblastoma; PD-L1; Tumor infiltrating lymphocytes (TIL); Neutrophil–lymphocyte ratio (NLR); Lymphocytopenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 464
页数：11
相关论文
共 50 条
  • [1] PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma
    Noronha, Carolina
    Ribeiro, Ana Sofia
    Taipa, Ricardo
    Leitao, Dina
    Schmitt, Fernando
    Reis, Joaquim
    Faria, Claudia
    Paredes, Joana
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2022, 156 (03) : 453 - 464
  • [2] PD-L1 Expression is Associated With Poor Prognosis in Renal Cell Carcinoma
    Carlsson, Jessica
    Sundqvist, Pernilla
    Kosuta, Vezira
    Falt, Anna
    Giunchi, Francesca
    Fiorentino, Michelangelo
    Davidsson, Sabina
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (03) : 213 - 220
  • [3] PD-L1 expression is common and indicates poor prognosis
    Clemens Thoma
    [J]. Nature Reviews Urology, 2016, 13 (1) : 5 - 5
  • [4] Expression of PD-L1 is associated with poor prognosis in breast cancer: A meta-analysis
    Zhang, M.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [5] Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
    Pu, Yunzhou
    Ji, Qing
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] PD-L1 EXPRESSION AND COMBINED PATTERN OF PD-L1/PD-1+TIMC DENSITY PREDICT PROGNOSIS IN GLIOBLASTOMA PATIENTS
    Lee, Youn Soo
    Han, Jiheun
    Hong, Yong-Kil
    [J]. NEURO-ONCOLOGY, 2016, 18 : 113 - 113
  • [7] PD1 and PD-L1 expression in glioblastoma
    Berghoff, Anna Sophie
    Kiesal, Barbara
    Widhalm, Georg
    Rajky, Orsolya
    Ricken, Garda
    Woehrer, Adelheid
    Dieckmann, Karin
    Filipits, Martin
    Zielinski, Christoph
    Marosi, Christine
    Hainfellner, Johannes A.
    Preusser, Matthias
    Wick, Wolfgang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] PD-L1 EXPRESSION IS ASSOCIATED WITH TUMOR PROGRESSION AND POOR PROGNOSIS IN XP11.2 TRANSLOCATION RENAL CELL CARCINOMA
    Qu, Yuan-Yuan
    Chang, Kun
    Xiao, Wen-Jun
    Zhang, Hai-Liang
    Ye, Ding-Wei
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1071 - E1071
  • [9] BDNF expression in GISTs predicts poor prognosis when associated with PD-L1 positive tumor-infiltrating lymphocytes
    Tian, Guang-Ang
    Xu, Wen-Ting
    Sun, Yue
    Wang, Jin
    Ke, Qing
    Yuan, Meng-Jiao
    Wang, Jin-Jin
    Zhuang, Chun
    Gong, Qian
    [J]. ONCOIMMUNOLOGY, 2021, 10 (01):
  • [10] Loss of tumor HLA class I and PD-L1 expression in bladder cancer is associated with higher tumor grade and poor survival prognosis
    Gil-Julio, Hernani
    Perea, Francisco
    Torres, Cristina
    Manuel Cozar, Jose
    Garrido, Federico
    Aptsiauri, Natalia
    Ruiz-Cabello, Francisco
    [J]. HLA, 2022, 99 (05) : 448 - 449
12345